Lipid Profiles, Inflammatory Markers, and Insulin Therapy in Youth with Type 2 Diabetes

Keyphrases

• Type 2 Diabetes Mellitus (T2DM) 100%
• Inflammatory Markers 100%
• Lipid Profile 100%
• Glycemic Control 100%
• Insulin Therapy 100%
• Hemoglobin A1c (HbA1c) 60%
• Dyslipidemia 40%
• Inflammation 40%
• Low-density Lipoprotein Cholesterol (LDL-C) 40%
• Insulin 40%
• Lipid Biomarkers 40%
• Treatment Options 20%
• Multicenter Trial 20%
• Triglycerides 20%
• Cholesterol 20%
• Trial Registration 20%
• High-sensitivity C-reactive Protein (hs-CRP) 20%
• Apolipoprotein B (Apo B) 20%
• Statins 20%
• Statin Use 20%
• Atherogenic Dyslipidemia 20%
• Non-esterified Fatty Acids 20%
• Glycated Hemoglobin A1c 20%
• Insulin Initiation 20%
• Uncontrolled Type 2 Diabetes 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Insulin Dependent Diabetes Mellitus 100%
• Hemoglobin A1c 80%
• Dyslipidemia 60%
• Inflammation 40%
• Low Density Lipoprotein Cholesterol 40%
• Prematurity 20%
• C Reactive Protein 20%
• Fatty Acid 20%
• Triacylglycerol 20%
• Atherosclerosis 20%
• Statin (Protein) 20%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 20%
• Apolipoprotein B 20%